Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Using sevoflurane to treat chronic leg ulcers

Official title: Analgesic and Healing Effect of Topical Sevoflurane for Chronic Venous Ulcers

Run by Charles University, Czech Republic · NCT05303805 · Data updated 2026-11-12

This study tests if using sevoflurane on painful leg ulcers can help reduce pain and improve healing compared to a regular rinse solution.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations1 site (Prague)
StatusRecruiting
StartedMay 2, 2022
Main results expectedOctober 30, 2027
Study endsJanuary 31, 2028
Registry record updatedOctober 27, 2026
Trial IDNCT05303805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients suffering from painful, non-healing tibial venous ulcers with a pain intensity rating above 4.

Probably not a fit

Patients with an allergy to sevoflurane or those unable to understand the pain-intensity questionnaire will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of topical sevoflurane in treating painful, non-healing leg ulcers. Patients will be randomly assigned to receive either sevoflurane or a standard rinse solution during their wound treatment. The study will monitor pain intensity, microbial colonization, and the healing process over a period of five days. The primary focus is on pain relief, with secondary outcomes related to ulcer healing and microbial management.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce pain and improve healing outcomes for patients with chronic leg ulcers.

How similar studies have gone: While the use of sevoflurane in this context is novel, similar approaches in pain management and wound healing have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with painful (pain intensity on the numerical scale NRS 0-10 is NRS\>4) non- healing tibial venous ulcers

Exclusion Criteria:

* Allergy to sevoflurane
* Inability to understand the pain-intensity questionnaire

Where it's running

  • Faculty Hospital Kralovske Vinohrady
    Prague, Czechia
    Recruiting

Study contacts

  • Principal investigator: Jiří Málek, M.D. — 3rd Medical Faculty of Charles University
  • Study coordinator: Jiri Malek, M.D.
  • Email: malekj@fnkv.cz
  • Phone: +4202671622461

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.